SCHEMBL868308

SCHEMBL868308

Fc1c2nc(c(F)c3ccc(cc4nc(cc5ccc1[nH]5)C=C4)[nH]3)C=C2

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.48
▸ STAT1 P42224 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL722603 0.95 STAT3 (0.50) STAT3STAT1
SCHEMBL7877923 0.91 STAT3 (0.42) STAT3STAT1
SCHEMBL899159 0.86 STAT3 (0.71) STAT3STAT1
SCHEMBL224519 0.83 STAT3 (0.48) STAT3STAT1
SCHEMBL30426808 0.80 STAT3 (0.56) STAT3STAT1
SCHEMBL1978627 0.80 STAT3 (0.56) STAT3STAT1
SCHEMBL1290623 0.80 STAT3 (0.56) STAT3STAT1
SCHEMBL80002 0.79 STAT3 (0.48) STAT3STAT1
SCHEMBL9754334 0.79 STAT3 (0.48) STAT3STAT1
SCHEMBL869195 0.79 STAT3 (0.48) STAT3STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140243294-A1 METHOD OF ACTIVATION OF OXAZAPHOSPHORINES DUKE UNIVERSITY (US) 2014-08-28 — — US disclosed
US-8759324-B2 Method of activation of oxazaphosphorines DUKE UNIVERSITY (US) 2014-06-24 — — US disclosed
US-20130172296-A1 METHOD OF ACTIVATION OF OXAZAPHOSPHORINES UNIV DUKE (US) 2013-07-04 — — US disclosed
US-8399434-B2 Method of activation of oxazaphosphorines DUKE UNIVERSITY (US) 2013-03-19 — — US disclosed
US-20120077782-A9 METHOD OF ACTIVATION OF OXAZAPHOSPHORINES DUKE UNIVERSITY (US) 2012-03-29 — — US disclosed
US-20090318388-A1 METHOD OF ACTIVATION OF OXAZAPHOSPHORINES DUKE UNIVERSITY (US) 2009-12-24 — — US disclosed
WO-2008073195-A2 METHOD FOR ACTIVATION OF OXAZAPHOSPHORINES DUKE UNIVERSITY (US) 2008-06-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318388-A1 METHOD OF ACTIVATION OF OXAZAPHOSPHORINES PPOX, HMBS, OAT STAT3 3574/4885STAT1 3297/4885
US-20140243294-A1 METHOD OF ACTIVATION OF OXAZAPHOSPHORINES PPOX, HMBS, OAT STAT3 3574/4885STAT1 3297/4885
US-20120077782-A9 METHOD OF ACTIVATION OF OXAZAPHOSPHORINES PPOX, HMBS, OAT STAT3 3574/4885STAT1 3297/4885
US-20130172296-A1 METHOD OF ACTIVATION OF OXAZAPHOSPHORINES PPOX, HMBS, OAT STAT3 3574/4885STAT1 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback